• 1
    Schipper H, Clinch J, Olweny CLM. Quality of life studies: definitions and conceptual issues. In: SpilkerB, editor. Quality of Life and Pharmacoeconomics in Cinical Trials. Philadelphia: Lippincot-Raven Press, 1990: 1123.
  • 2
    Guyatt GH, Naylor CD, Juniper E, Heyland DK, Jaeschke R, Cook DJ. Users’ guides to the medical literature. XII – how to use articles about health-related quality of life. JAMA 1997;277: 12321237.
  • 3
    Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. Ann Intern Med 1993;118: 622629.
  • 4
    Smith KW, Avis NE, Assmann SF. Distinguishing between quality of life and health status in quality of life research: a meta-analysis. Quality of Life Research 1999;8: 447459.
  • 5
    Baiardini I, Pasquali M, Giardini A, Majani G, Canonica GW. Quality of life in respiratoriy allergy. Allergy Asthma Proc. 2001;22: 177181.
  • 6
    Juniper EF, Howland WC, Roberts NB, Thompson AK, King DR. Measuring quality of life in children with rhinoconjunctivitis. J Allergy Clin Immunol 1998;101: 163170.
  • 7
    Juniper EF, Guyatt GH, Feeny DH, Ferrie PJ, Griffith LE, Townsend M. Measuring quality of life in children with asthma. Qual Life Res 1996;5: 3546.
  • 8
    Juniper EF, Guyatt GH, Dolovich J. Assessment of quality of life in adolescents with allergic rhinoconjunctivitis: development and testing of a questionnaire for clinical trials. J Allergy Clin Immunol 1994;93: 413423.
  • 9
    Juniper EF, Guyatt GH. Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis. Clin Exp Allergy 1991;21: 7783.
  • 10
    Juniper EF, Guyatt GH, Epstein RS et al. Evaluation of impairment of health- related quality of life in asthma: development of a questionnaire for use in clinical trials. Thorax 1992;47: 7683.
  • 11
    Hyland ME. The living with asthma questionnaire. Respir Med 1991;83: 1316.
  • 12
    De Graaf-in ‘t Veld T, Koenders S, Garrelds IM, van Gerth Wijk R. Relationship between nasal hyperreactivity, quality of life and nasal symptoms in perennial rhinitis. J Allergy Clin Immunol 1996;98: 508513.
  • 13
    Bousquet J, Bullinger M, Fayol C et al. Assessment of quality of life in patients with perennial allergic rhinitis with the French version of the SF-36 Health Status Questionnaire. J Allergy Clin Immunol 1994;94: 182188.
  • 14
    Majani G, Baiardini I, Giardini A et al. Quality of life assessment in young adults with seasonal allergic rhinitis during and after the pollen season. Allergy 2001;56: 313317.
  • 15
    Juniper EF. Impact of upper respiratory allergic diseases on quality of life. J Allergy ClinImmunol 1998;101: 386391.
  • 16
    Bousquet J, Knani J, Dhivert H et al. Quality of life in asthma. Internal consistency and validity of the SF-36 questionnaire. Am Respir Crit Car Med 1994;149: 371375.
  • 17
    Barley EA, Jones PW. A comparison of global questions versus health status questionnaires as measures of the severity and impact of asthma. Eur Respir J 1999;14: 591596.
  • 18
    Bousquet J, Duchateau J, Pignat JC et al. Improvement of quality of life by treatment with cetirizine in patients with perennial allergic rhinitis as determined by a French version of the SF-36 questionnaire. J Allergy Clin Immunol 1996;98: 309316.
  • 19
    Meltzer EO, Casale TB, Nathan RA, Thompson AK. Once-daily fexofenadine HC1 improves quality of life and reduces work and activity impairment in pateints with seasonal allergic rhinitis. Ann Allergy Asthma Immuno 1999;183: 311317.
  • 20
    Juniper EF, Guyatt GH, Archer B et al. Aqueous beclomethasone dipropionate in the treatment of ragweed pollen-induced rhinitis: further exploration of ‘as needed’ use. J Allergy Clin Immunol 1993;92: 6672.
  • 21
    Juniper EF, Johnston PR, Borkhoff CM et al. Quality of life in asthma clinical trials: comparison of salmeterol and salbutamol. Am J Respir Crit Care Med 1995;151: 6670.
  • 22
    Spector SL. Overview of comorbid associations of allergic rhinitis. J Allergy Clin Immunol 1997;99: 773780.
  • 23
    Passalacqua G, Ciprandi G, Canonica GW. United airways disease: therapeutic aspects. Thorax 2000;55(2):2627.
  • 24
    Passalacqua G, Ciprandi G, Canonica GW. The nose-lung interaction in allergic rhinitis and asthma: the United Airways Disease. Curr Opinion 2001;1: 713.
  • 25
    Altman DG. Practical statistics for medical research. London: Chapman & Hall, 2001.
  • 26
    Leynaert BJ, Bousquet J, Neukirch C, Liard R, Neukirch F. Perennial rhinitis: an independent risk factor for asthma in non atopic subjects: results from the European Community Respiratory Health Survey. J Allergy Clin Immunol 1999;104: 301304.